Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma

NCT01168791 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

447

Enrollment

INDUSTRY

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: doxorubicin in combination with palifosfamide-tris
DRUG: doxorubicin in combination with placebo

Sponsor

Alaunos Therapeutics